- Home
- BSX vs UBS Comparison
BSX vs UBS Comparison
Compare BSX & UBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSX
- UBS
- Stock Information
- Founded
- BSX 1979
- UBS 1862
- Country
- BSX United States
- UBS Switzerland
- Employees
- BSX N/A
- UBS N/A
- Industry
- BSX Medical/Dental Instruments
- UBS Major Banks
- Sector
- BSX Health Care
- UBS Finance
- Exchange
- BSX Nasdaq
- UBS Nasdaq
- Market Cap
- BSX 157.6B
- UBS 122.4B
- IPO Year
- BSX 1992
- UBS N/A
- Fundamental
- Price
- BSX $97.80
- UBS $41.48
- Analyst Decision
- BSX Strong Buy
- UBS Buy
- Analyst Count
- BSX 22
- UBS 3
- Target Price
- BSX $118.91
- UBS N/A
- AVG Volume (30 Days)
- BSX 7.8M
- UBS 1.5M
- Earning Date
- BSX 10-22-2025
- UBS 10-29-2025
- Dividend Yield
- BSX N/A
- UBS 1.79%
- EPS Growth
- BSX 36.90
- UBS 232.88
- EPS
- BSX 1.68
- UBS 1.89
- Revenue
- BSX $18,494,000,000.00
- UBS $47,011,000,000.00
- Revenue This Year
- BSX $19.75
- UBS $3.27
- Revenue Next Year
- BSX $11.03
- UBS $3.23
- P/E Ratio
- BSX $58.59
- UBS $20.94
- Revenue Growth
- BSX 21.44
- UBS 1.24
- 52 Week Low
- BSX $80.64
- UBS $25.75
- 52 Week High
- BSX $109.50
- UBS $41.71
- Technical
- Relative Strength Index (RSI)
- BSX 27.06
- UBS 64.99
- Support Level
- BSX $104.24
- UBS $39.72
- Resistance Level
- BSX $109.50
- UBS $41.71
- Average True Range (ATR)
- BSX 2.15
- UBS 0.42
- MACD
- BSX -1.07
- UBS 0.00
- Stochastic Oscillator
- BSX 5.19
- UBS 90.87
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
About UBS UBS Group AG Registered
The core of UBS is its global wealth management business focusing on high and ultra-high-net-worth individuals. UBS is also a conventional retail and commercial bank in its Swiss home market. Its investment bank and asset management businesses support its wealth management operations, but also leverage its strength in wealth management to serve third-party clients.